vorinostat has been researched along with Anaplastic Ependymoma in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gorsi, HS | 1 |
Toll, SA | 1 |
Sood, S | 1 |
Miler, S | 1 |
Altinok, D | 1 |
Kumar-Sinha, C | 1 |
Mody, R | 1 |
Yankelevich, M | 1 |
Milde, T | 1 |
Kleber, S | 1 |
Korshunov, A | 1 |
Witt, H | 1 |
Hielscher, T | 1 |
Koch, P | 1 |
Kopp, HG | 1 |
Jugold, M | 1 |
Deubzer, HE | 1 |
Oehme, I | 1 |
Lodrini, M | 1 |
Gröne, HJ | 1 |
Benner, A | 1 |
Brüstle, O | 1 |
Gilbertson, RJ | 1 |
von Deimling, A | 1 |
Kulozik, AE | 1 |
Pfister, SM | 1 |
Martin-Villalba, A | 1 |
Witt, O | 1 |
2 other studies available for vorinostat and Anaplastic Ependymoma
Article | Year |
---|---|
Ongoing Response in a Multiply Relapsed Metastatic Posterior Fossa Ependymoma A After Vorinostat and Concomitant Irradiation.
Topics: Child, Preschool; Combined Modality Therapy; Ependymoma; Histone Deacetylase Inhibitors; Humans; Mal | 2022 |
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Ependymoma; Gene Expression Profiling; Histone Deac | 2011 |